142 related articles for article (PubMed ID: 24918535)
1. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.
Tracz A; Madzio J; Gnys P; Malachowska B; Borowiec M; Wyka K; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Mlynarski W; Fendler W;
Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535
[TBL] [Abstract][Full Text] [Related]
2. HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2).
Borowiec M; Fendler W; Dusatkova P; Antosik K; Pruhova S; Cinek O; Mysliwiec M; Jarosz-Chobot P; Malecki MT; Mlynarski W
Diabet Med; 2012 Nov; 29(11):1465-9. PubMed ID: 22486180
[TBL] [Abstract][Full Text] [Related]
3. Genotype effects of glucokinase regulator on lipid profiles and glycemic status are modified by circulating calcium levels: results from the Korean Genome and Epidemiology Study.
Kim OY; Kwak SY; Lim H; Shin MJ
Nutr Res; 2018 Dec; 60():96-105. PubMed ID: 30527264
[TBL] [Abstract][Full Text] [Related]
4. Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.
Fendler W; Rizzo M; Borowiec M; Malachowska B; Antosik K; Szadkowska A; Banach M; Urbanska-Kosinska M; Szopa M; Malecki M; Mlynarski W
Acta Diabetol; 2014 Aug; 51(4):625-32. PubMed ID: 24549415
[TBL] [Abstract][Full Text] [Related]
5. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
[TBL] [Abstract][Full Text] [Related]
6. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
[TBL] [Abstract][Full Text] [Related]
7. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
Ping F; Fu J; Xiao X
Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
[TBL] [Abstract][Full Text] [Related]
10. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
11. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
[TBL] [Abstract][Full Text] [Related]
12. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Wang H; Liu L; Zhao J; Cui G; Chen C; Ding H; Wang DW
PLoS One; 2013; 8(6):e67665. PubMed ID: 23840762
[TBL] [Abstract][Full Text] [Related]
13. Association of
Ansari N; Ramachandran V; Mohamad NA; Salim E; Ismail P; Hazmi M; Mat LNI
Glob Med Genet; 2023 Jan; 10(1):12-18. PubMed ID: 36703777
[No Abstract] [Full Text] [Related]
14. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study.
Hishida A; Morita E; Naito M; Okada R; Wakai K; Matsuo K; Nakamura K; Takashima N; Suzuki S; Takezaki T; Mikami H; Ohnaka K; Watanabe Y; Uemura H; Kubo M; Tanaka H; Hamajima N
Endocr J; 2012; 59(7):589-99. PubMed ID: 22517333
[TBL] [Abstract][Full Text] [Related]
15. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
[TBL] [Abstract][Full Text] [Related]
16. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
17. Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study.
She L; Li W; Guo Y; Zhou J; Liu J; Zheng W; Dai A; Chen X; Wang P; He H; Zhang P; Zeng J; Xiang B; Li S; Wang L; Dai Q; Yang M
Gene; 2022 May; 824():146378. PubMed ID: 35276241
[TBL] [Abstract][Full Text] [Related]
18. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study.
Ling Y; Li X; Gu Q; Chen H; Lu D; Gao X
BMC Med Genet; 2011 May; 12():66. PubMed ID: 21569451
[TBL] [Abstract][Full Text] [Related]
19. Gene-gene interactions lead to higher risk for development of type 2 diabetes in a Chinese Han population: a prospective nested case-control study.
Zhou W; Li Y; Zhang L; Shi Y; Wang C; Zhang D; Liu X; Mao Z; Li L
Lipids Health Dis; 2018 Jul; 17(1):179. PubMed ID: 30055620
[TBL] [Abstract][Full Text] [Related]
20. Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Zusi C; Rinaldi E; Bonetti S; Boselli ML; Trabetti E; Malerba G; Bonora E; Bonadonna RC; Trombetta M
J Endocrinol Invest; 2021 Dec; 44(12):2567-2574. PubMed ID: 34128214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
